A Phase I Study Of BG [benzylguanine] In Combination With Ifosfamide For Advanced Solid Tumors

Trial Profile

A Phase I Study Of BG [benzylguanine] In Combination With Ifosfamide For Advanced Solid Tumors

Discontinued
Phase of Trial: Phase I

Latest Information Update: 23 Jan 2013

At a glance

  • Drugs Benzylguanine (Primary) ; Ifosfamide
  • Indications Solid tumours
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 19 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top